SNMMI concerned about oncology coverage guidelines

William Doss | October 10, 2016 | Radiology Business | Nuclear Medicine

The Society of Nuclear Medicine and Molecular Imaging expressed their concern with an updated list of oncology coding recommendations released by eviCore, a benefits management company.

eviCore will no longer cover vluiciclovinem, choline or GA DOTATE for PET imaging, citing that the scans are "considered investigational and experimental for all indications for prostate cancer at this time." SNMMI will continue to follow the issue and is working with patient advocay groups to formulate a response.

Follow the link below to learn more about these updated coverage guidelines:

Updated eviCore Oncology Guidelines Cover Only FDG for PET Imaging

William Doss

As a Senior Writer for TriMed Media Group, Will covers radiology practice improvement, policy, and finance. He lives in Chicago and holds a bachelor’s degree in Life Science Communication and Global Health from the University of Wisconsin-Madison. He previously worked as a media specialist for the UW School of Medicine and Public Health. Outside of work you might see him at one of the many live music venues in Chicago or walking his dog Holly around Lakeview.

Related Content